Silence Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Silence Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silence Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silence Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.6M | 307k | 5.19 |
| 2025-06-30 | $1.3M | 229k | 5.80 |
| 2025-03-31 | $901k | 320k | 2.82 |
| 2024-12-31 | $2.4M | 356k | 6.88 |
| 2024-09-30 | $1.3M | 71k | 18.18 |
| 2024-06-30 | $1.4M | 74k | 19.00 |
| 2024-03-31 | $1.6M | 72k | 21.60 |
| 2023-12-31 | $1.2M | 70k | 17.37 |
| 2023-09-30 | $679k | 69k | 9.82 |
| 2023-06-30 | $386k | 70k | 5.50 |
| 2023-03-31 | $428k | 69k | 6.20 |
| 2022-12-31 | $1.1M | 69k | 15.25 |
| 2022-09-30 | $648k | 66k | 9.84 |
| 2022-06-30 | $821k | 69k | 11.85 |
| 2022-03-31 | $1.3M | 69k | 19.34 |
| 2021-12-31 | $1.7M | 70k | 23.90 |
| 2020-12-31 | $2.0k | 93 | 21.51 |